Prescriptions made by Lewis C Sommerville

Data for 2018

2,553

Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 230 providers in this state and specialty

$796.9K

Total Retail Price of All Prescriptions

Rank: 68 out of 230 providers in this state and specialty

375

Patients Receiving at Least One Drug in Part D

Rank: 45 out of 230 providers in this state and specialty

79%

Patients 65 Years and Older

71

Average Age of Patients

Average age of patients for providers in this state and specialty is 69

Drug Categories

O

Opioid

An opioid drug. Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.
A

Antibiotic

Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.
P

Antipsychotic

Used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders.

Prescription Data

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume. Rank in State ranks all providers that have the self-identified specialty of Pulmonary Disease in Tennessee and ranks the number of prescriptions that have been made for the specific drug.

Drug Name Rank in State Total Prescriptions Filled with Refills Prescript. to 65+ Patients Receiving this Drug Patients 65+ OAP
1 BREO ELLIPTA
(FLUTICASONE/VILANTEROL)
260
of 1640
2340 prescriptions
Less than 1% of all prescriptions
1590480 patients
13% of all patients
320 patients
9% of all patients
2 SYMBICORT
(BUDESONIDE/FORMOTEROL FUMARATE)
220
of 1760
2310 prescriptions
Less than 1% of all prescriptions
1870560 patients
15% of all patients
440 patients
12% of all patients
3 MONTELUKAST SODIUM460
of 1600
1400 prescriptions
Less than 1% of all prescriptions
960360 patients
10% of all patients
< 11
4 ADVAIR DISKUS
(FLUTICASONE PROPION/SALMETEROL)
320
of 1570
1220 prescriptions
Less than 1% of all prescriptions
920320 patients
9% of all patients
< 11
5 PROAIR HFA
(ALBUTEROL SULFATE)
180
of 1750
2270 prescriptions
Less than 1% of all prescriptions
1670750 patients
20% of all patients
530 patients
14% of all patients
6 VENTOLIN HFA
(ALBUTEROL SULFATE)
180
of 1770
2140 prescriptions
Less than 1% of all prescriptions
1480800 patients
21% of all patients
650 patients
17% of all patients
7 SPIRIVA
(TIOTROPIUM BROMIDE)
410
of 1730
1020 prescriptions
Less than 1% of all prescriptions
720260 patients
7% of all patients
< 11
8 COMBIVENT RESPIMAT
(IPRATROPIUM/ALBUTEROL SULFATE)
40
of 990
1210 prescriptions
Less than 1% of all prescriptions
600200 patients
5% of all patients
< 11
9 ANORO ELLIPTA
(UMECLIDINIUM BRM/VILANTEROL TR)
440
of 1460
810 prescriptions
Less than 1% of all prescriptions
690160 patients
4% of all patients
< 11
10 PREDNISONE410
of 1770
1710 prescriptions
Less than 1% of all prescriptions
1360880 patients
23% of all patients
680 patients
18% of all patients
11 FLUTICASONE PROPIONATE480
of 1390
400 prescriptions
Less than 1% of all prescriptions
400130 patients
3% of all patients
130 patients
3% of all patients
12 SPIRIVA RESPIMAT
(TIOTROPIUM BROMIDE)
330
of 1270
600 prescriptions
Less than 1% of all prescriptions
120 patients
3% of all patients
< 11
13 AZITHROMYCIN340
of 1380
730 prescriptions
Less than 1% of all prescriptions
570190 patients
5% of all patients
< 11A
14 THEOPHYLLINE ANHYDROUS110
of 330
270 prescriptions
Less than 1% of all prescriptions
< 11< 11
15 TRELEGY ELLIPTA
(FLUTICASONE/UMECLIDIN/VILANTER)
370
of 1120
370 prescriptions
Less than 1% of all prescriptions
370160 patients
4% of all patients
160 patients
4% of all patients
16 FLOVENT HFA
(FLUTICASONE PROPIONATE)
230
of 660
250 prescriptions
Less than 1% of all prescriptions
120< 11< 11
17 INCRUSE ELLIPTA
(UMECLIDINIUM BROMIDE)
610
of 1470
340 prescriptions
Less than 1% of all prescriptions
230120 patients
3% of all patients
< 11
18 POTASSIUM CHLORIDE150
of 330
250 prescriptions
Less than 1% of all prescriptions
250< 11< 11
19 ETHAMBUTOL HCL30
of 150
220 prescriptions
Less than 1% of all prescriptions
110< 11< 11
20 DALIRESP
(ROFLUMILAST)
360
of 690
190 prescriptions
Less than 1% of all prescriptions
< 11< 11
21 ADVAIR HFA
(FLUTICASONE PROPION/SALMETEROL)
220
of 580
220 prescriptions
Less than 1% of all prescriptions
< 11< 11
22 RIFAMPIN30
of 180
220 prescriptions
Less than 1% of all prescriptions
110< 11< 11
23 FUROSEMIDE380
of 760
170 prescriptions
Less than 1% of all prescriptions
170< 11< 11
24 DOXYCYCLINE HYCLATE160
of 840
520 prescriptions
Less than 1% of all prescriptions
420 patients
11% of all patients
< 11A
25 AZELASTINE HCL230
of 470
140 prescriptions
Less than 1% of all prescriptions
< 11< 11
26 STIOLTO RESPIMAT
(TIOTROPIUM BR/OLODATEROL HCL)
400
of 770
130 prescriptions
Less than 1% of all prescriptions
< 11< 11
27 BEVESPI AEROSPHERE
(GLYCOPYRROLATE/FORMOTEROL FUM)
270
of 420
130 prescriptions
Less than 1% of all prescriptions
130< 11< 11
28 CLONAZEPAM280
of 430
160 prescriptions
Less than 1% of all prescriptions
160< 11< 11
29 BUSPIRONE HCL70
of 90
130 prescriptions
Less than 1% of all prescriptions
< 11< 11
30 ARNUITY ELLIPTA
(FLUTICASONE FUROATE)
290
of 490
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
31 NYSTATIN50
of 230
310 prescriptions
Less than 1% of all prescriptions
160 patients
4% of all patients
< 11
32 ESBRIET
(PIRFENIDONE)
240
of 530
120 prescriptions
Less than 1% of all prescriptions
< 11< 11
33 WARFARIN SODIUM170
of 230
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
34 SULFAMETHOXAZOLE-TRIMETHOPRIM
(SULFAMETHOXAZOLE/TRIMETHOPRIM)
110
of 400
300 prescriptions
Less than 1% of all prescriptions
260 patients
7% of all patients
< 11A
35 AMOXICILLIN-CLAVULANATE POTASS
(AMOXICILLIN/POTASSIUM CLAV)
230
of 680
290 prescriptions
Less than 1% of all prescriptions
260 patients
7% of all patients
< 11A
36 FLUCONAZOLE30
of 230
520 prescriptions
Less than 1% of all prescriptions
110 patients
3% of all patients
< 11
37 CEFUROXIME
(CEFUROXIME AXETIL)
110
of 160
170 prescriptions
Less than 1% of all prescriptions
150 patients
4% of all patients
< 11A